Sapphiros AI Bio LLC announced that it has raised $30 million in a round of funding led by new investor, OraSure Technologies, Inc. on January 4, 2024. The company issued common shares in the transaction. As a part of transaction, the investor became the part of board of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.86 USD | -3.67% | -11.48% | -40.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.73% | 372M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
+13.67% | 25.02B |
- Stock Market
- Equities
- OSUR Stock
- News OraSure Technologies, Inc.
- Sapphiros AI Bio LLC announced that it has received $30 million in funding from OraSure Technologies, Inc.